Alpha Modus Sues Walgreens for Patent Infringement, Strengthening Its Leadership in AI-Driven Retail Innovation
Alpha Modus Holdings (NASDAQ: AMOD) has filed a patent infringement lawsuit against Walgreens in the Eastern District of Texas, alleging willful infringement of its AI-driven retail technology patents. The lawsuit focuses on Walgreens' use of Cooler Screens digital smart screens, which Alpha Modus claims mirrors their patented innovations.
The company estimates potential damages exceeding $500 million, potentially reaching billions over the patent life. This legal action follows similar suits against other retailers including Kroger, Cooler Screens, and Wakefern, with the first trial scheduled for November 2025.
The announcement comes amid Walgreens' separate $200 million legal dispute with Cooler Screens over alleged contract breaches. Alpha Modus recently experienced significant market activity, with its stock trading volume exceeding 25 times its public float following a January 30, 2025 press release addressing market speculation and its SPAC merger.
Alpha Modus Holdings (NASDAQ: AMOD) ha intentato una causa per violazione di brevetto contro Walgreens nel Distretto Orientale del Texas, accusando una violazione volontaria dei suoi brevetti sulla tecnologia retail basata su intelligenza artificiale. La causa si concentra sull'uso da parte di Walgreens degli schermi digitali intelligenti Cooler Screens, che Alpha Modus sostiene rispecchino le proprie innovazioni brevettate.
L'azienda stima danni potenziali superiori a 500 milioni di dollari, con la possibilità che arrivino a miliardi entro la vita del brevetto. Questa azione legale segue cause simili contro altri rivenditori, tra cui Kroger, Cooler Screens e Wakefern, con il primo processo programmato per novembre 2025.
L'annuncio arriva in mezzo a una separata controversia legale da 200 milioni di dollari di Walgreens con Cooler Screens per presunti inadempimenti contrattuali. Alpha Modus ha recentemente vissuto un'attività di mercato significativa, con il suo volume di scambi azionari che supera 25 volte il flottante pubblico dopo un comunicato stampa del 30 gennaio 2025 che affrontava le speculazioni di mercato e la sua fusione SPAC.
Alpha Modus Holdings (NASDAQ: AMOD) ha presentado una demanda por infracción de patente contra Walgreens en el Distrito Este de Texas, alegando infracción intencional de sus patentes sobre tecnología minorista impulsada por inteligencia artificial. La demanda se centra en el uso por parte de Walgreens de las pantallas digitales inteligentes de Cooler Screens, que Alpha Modus afirma que reflejan sus innovaciones patentadas.
La empresa estima daños potenciales que superan los 500 millones de dólares, potencialmente alcanzando miles de millones a lo largo de la vida de la patente. Esta acción legal sigue a demandas similares contra otros minoristas, incluyendo Kroger, Cooler Screens y Wakefern, con el primer juicio programado para noviembre de 2025.
El anuncio se produce en medio de una disputa legal separada de Walgreens por 200 millones de dólares con Cooler Screens por supuestas violaciones de contrato. Alpha Modus experimentó recientemente una actividad significativa en el mercado, con un volumen de negociación de acciones que supera 25 veces su flotación pública después de un comunicado de prensa del 30 de enero de 2025 que abordaba la especulación del mercado y su fusión SPAC.
Alpha Modus Holdings (NASDAQ: AMOD)는 Walgreens를 상대로 텍사스 동부 지방 법원에 특허 침해 소송을 제기하며, AI 기반 소매 기술 특허의 고의적인 침해를 주장했습니다. 소송은 Walgreens가 Cooler Screens 디지털 스마트 스크린을 사용하는 것에 초점을 맞추고 있으며, Alpha Modus는 이들이 자신들의 특허받은 혁신을 반영하고 있다고 주장하고 있습니다.
회사는 잠재적 손해액이 5억 달러를 초과할 것으로 추정하며, 특허의 수명에 따라 수십억에 이를 수 있다고 보고 있습니다. 이 법적 조치는 Kroger, Cooler Screens, Wakefern을 포함한 다른 소매업체들에 대한 유사한 소송에 이어진 것이며, 첫 재판은 2025년 11월로 예정되어 있습니다.
이 발표는 Walgreens가 Cooler Screens와의 계약 위반 주장으로 2억 달러를 둘러싼 별도의 법적 분쟁 중에 나온 것입니다. Alpha Modus는 최근 시장에서 상당한 활동을 경험했으며, 2025년 1월 30일 발표된 보도자료 이후 주식 거래량이 공모 수의 25배를 초과했습니다.
Alpha Modus Holdings (NASDAQ: AMOD) a déposé une plainte pour violation de brevet contre Walgreens dans le district est du Texas, alléguant une violation intentionnelle de ses brevets sur la technologie de vente au détail alimentée par l'intelligence artificielle. Le procès se concentre sur l'utilisation par Walgreens des écrans intelligents numériques de Cooler Screens, que Alpha Modus affirme reflètent ses innovations brevetées.
La société estime que les dommages potentiels dépassent 500 millions de dollars, pouvant atteindre des milliards tout au long de la durée du brevet. Cette action en justice fait suite à des poursuites similaires contre d'autres détaillants, y compris Kroger, Cooler Screens et Wakefern, avec le premier procès prévu pour novembre 2025.
L'annonce survient dans le cadre d'un litige séparé de 200 millions de dollars entre Walgreens et Cooler Screens pour des violations présumées de contrat. Alpha Modus a récemment connu une activité significative sur le marché, avec un volume d'échanges de ses actions dépassant 25 fois son flottant public après un communiqué de presse du 30 janvier 2025 abordant la spéculation sur le marché et sa fusion SPAC.
Alpha Modus Holdings (NASDAQ: AMOD) hat im östlichen Distrikt Texas eine Klage wegen Patentverletzung gegen Walgreens eingereicht und wirft ihnen vorsätzliche Verletzung ihrer Patente für KI-gesteuerte Einzelhandelstechnologie vor. Der Rechtsstreit konzentriert sich auf die Verwendung von Cooler Screens digitalen Smart-Screens durch Walgreens, die laut Alpha Modus ihren patentierten Innovationen ähneln.
Das Unternehmen schätzt die potenziellen Schäden auf über 500 Millionen Dollar, die möglicherweise Milliarden während der Lebensdauer des Patents erreichen könnten. Diese rechtlichen Schritte folgen ähnlichen Klagen gegen andere Einzelhändler, darunter Kroger, Cooler Screens und Wakefern, wobei die erste Verhandlung für November 2025 angesetzt ist.
Die Bekanntgabe erfolgt inmitten eines separaten rechtlichen Streits von Walgreens über 200 Millionen Dollar mit Cooler Screens wegen angeblicher Vertragsverletzungen. Alpha Modus hat kürzlich signifikante Marktaktivitäten erlebt, wobei das Handelsvolumen seiner Aktien 25 Mal so hoch war wie der öffentliche Float nach einer Pressemitteilung vom 30. Januar 2025, die sich mit Marktspekulationen und seiner SPAC-Verschmelzung befasste.
- Potential damages from patent infringement could exceed $500 million
- Company holds nine AI patents in retail technology
- Strong market response with trading volume exceeding 25x public float
- Multiple ongoing patent enforcement actions against major retailers
- Outcome of patent litigation uncertain
- Legal proceedings could be lengthy and costly
- Revenue generation dependent on successful litigation
Insights
This patent infringement lawsuit against Walgreens marks a pivotal moment for Alpha Modus, representing not just a single legal action but a strategic move in the $500M+ potential damages landscape of retail technology IP enforcement. The lawsuit's timing is particularly strategic, coinciding with Walgreens' existing $200M legal dispute with Cooler Screens, potentially strengthening Alpha Modus's position.
The case has several critical implications:
- The estimated damages exceeding
$500 million suggest substantial commercial value in Alpha Modus's AI retail technology patents - The allegation of willful infringement could potentially triple damages under patent law
- Alpha Modus's aggressive IP enforcement strategy, with multiple ongoing lawsuits, signals strong confidence in their patent portfolio's validity
- The November 2025 trial date for their first case will likely set important precedents for subsequent litigation
The market's response, evidenced by trading volume exceeding 25 times the public float, suggests strong investor confidence in Alpha Modus's IP monetization strategy. This lawsuit, combined with their expanding patent portfolio (now at nine AI patents), positions Alpha Modus as a significant player in retail technology IP rights.
The financial implications of this litigation strategy are substantial and multifaceted. The claimed damages of
Key financial considerations include:
- The potential for multiple revenue streams through licensing agreements or settlements with various retailers
- Litigation costs could be significant but may be offset by contingency fee arrangements
- The company's aggressive IP enforcement strategy could lead to industry-wide licensing opportunities
- The recent SPAC merger provides financial resources to pursue litigation
The extraordinary trading volume surge following recent announcements indicates strong market interest in Alpha Modus's IP monetization strategy. This lawsuit against Walgreens, combined with other pending cases, positions the company for potential significant value creation through IP enforcement and licensing.
CORNELIUS, N.C., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Alpha Modus Holdings, Inc. (Nasdaq: AMOD) (“Company”) announced today that its wholly owned subsidiary, Alpha Modus, Corp. (“Alpha Modus”), has filed a patent infringement lawsuit that also alleges willful infringement against Walgreens Co. (“Walgreens”) in the United States District Court for the Eastern District of Texas. This legal action underscores Alpha Modus’s unwavering commitment to protecting its groundbreaking AI-driven retail technology and further solidifies its leadership in the rapidly evolving retail innovation landscape.
Championing Innovation and Protecting Shareholder Value
Alpha Modus has transformed AI-powered retail engagement with its extensive patent portfolio, including its latest—its ninth AI patent. Alpha Modus’s patented solutions are designed to enhance consumer experiences, improve retail efficiency, and boost revenue for retailers and brands.
“We believe our technology is currently being used by scores of brands, retailers and technology providers. Our research demonstrates that, as a result, damages due Alpha Modus far exceed an estimated
Alleged Patent Infringement Details
Walgreens allegedly willfully infringed on Alpha Modus’s patented AI-driven retail technology, which enhances in-store shopping through data-driven insights, interactive advertising, and consumer engagement tools. Walgreens’s deployment of Cooler Screens digital smart screens in its stores mirrors the innovations protected under Alpha Modus’s patents, necessitating this legal action.
A Pattern of Defending Innovation
This lawsuit follows recent actions Alpha Modus has taken against major retailers and technology providers, including Kroger, Cooler Screens, Wakefern, Shelf Nine LLC, VSBLTY Groupe Technologies, Brookshire Grocery, and Grocery TV. These cases reflect Alpha Modus’s commitment to protecting its technology and securing rightful recognition of its innovations. The first of these cases is set for trial in November 2025.
Meanwhile, Walgreens finds itself entangled in another legal dispute, with Cooler Screens recently filing a
Market Confidence and Unprecedented Momentum
Alpha Modus’s firm stance on intellectual property aligns with its broader strategic vision, as reaffirmed in a recent press release by CEO William Alessi. That announcement on January 30, 2025, which addressed Alessi's perspective on uninformed or ill-informed speculation in the Company’s stock, market volatility and Alpha Modus’s successful SPAC merger, triggered an unprecedented surge in AMOD stock trading volume, leading to AMOD stock trading over 25 times its public float—demonstrating strong investor confidence in the Company’s ability to achieve its long-term growth objectives.
“Alpha Modus remains committed to redefining retail technology,” added Alessi. “We are dedicated to delivering shareholder value, and this lawsuit reaffirms our commitment to innovation, fairness, and growth.”
About Alpha Modus
Alpha Modus Holdings, Inc. (Nasdaq: AMOD) is a pioneering technology company specializing in AI-driven retail solutions. The Company’s patented technologies optimize consumer engagement, enhance in-store experiences, and drive measurable returns for retailers and brands. For more information, visit www.alphamodus.com.
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Alpha Modus’s actual results may differ from their expectations, estimates, and projections, and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements, but are not the exclusive means of identifying these statements. These forward-looking statements include, without limitation, Alpha Modus’s expectations with respect to future performance.
Alpha Modus cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Alpha Modus does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based.
Contacts
Alpha Modus Holdings, Inc.
Investor Relations
ir@alphamodus.com
+1(704)252-5050
Follow us on LinkedIn
Follow us on X
FAQ
How much is Alpha Modus (AMOD) seeking in damages from Walgreens?
When is Alpha Modus's first patent infringement trial scheduled?
What technology is Alpha Modus (AMOD) claiming Walgreens infringed upon?
How many AI patents does Alpha Modus (AMOD) currently hold?
Which other companies has Alpha Modus (AMOD) filed patent infringement lawsuits against?
